Researchers at the John Innes Centre in the U.K. have created a genetically modified tomato that serves as a source for the amino acid l-3,4-dihydroxyphenylalanine (L-DOPA), which the brain converts into dopamine. The discovery could provide an affordable source for the medicine, which first hit the market in the 1960s. Then touted as a “miracle…